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ABSTRACT
More than one-third of the RAG1 protein can be
truncated from the N-terminus with only subtle
effects on the products of V(D)J recombination
in vitro or in a mouse. What, then, is the function
of the N-terminal domain? We believe it to be reg-
ulatory. We determined, several years ago, that an
included RING motif could function as an ubiquitin
E3 ligase. Whether this activity is limited to auto-
modification, or may alter other proteins in the
cell, remains an open question. We revisited the
issue of additional protein–protein interactions
between RAG1 and other proteins by means of the
yeast two-hybrid assay. We confirmed the interac-
tion already described with KPNA2/RCH1/SRP1a
and found two others—to the transcription factor
GMEB1/PIF p96 and the splicing factor SF3A2/
SF3a66. A luciferase reporter assay demonstrates
that a protein complex containing RAG proteins
and the transcription factor can assemble in cells.
Further mapping identified a region within the
N-terminal domain resembling a WW motif. Point
mutation directed at residues conserved in WW
motifs eliminated binding to one of the partners.
Phylogenetic analysis shows the WW-like module
to be highly conserved. The module contributes to
protein–protein interactions that may also influence
how RAG1 binds DNA targets.
INTRODUCTION
The adaptive immune response of vertebrate animals
depends upon site-speciﬁc DNA rearrangement in a pro-
cess termed ‘V(D)J recombination’. The combinatorial
nature of this gene assembly explains a large part of the
diversity witnessed in the resulting receptors, and permits
a ﬂexible response (1,2). The mechanism of the recombi-
nation reaction is known at the most general level.
Recombination is targeted to the sequences encoding
the V, D or J elements by the presence of adjacent recom-
bination signal sequences (RSSs). Two proteins, called
RAG1 and RAG2 (3,4), form the nuclease that recognizes
these targets and cuts the DNA into ends that are pro-
cessed and rejoined in a new conﬁguration. Aside from the
nuclease activity, there exists evidence that the RAG pro-
teins function at a structural level in the synapsis of
the two DNA targets and organization of the cut ends
after the cleavage reaction. It is also possible that RAG1
functions at yet another level, as a regulatory molecule
controlling V(D)J recombination and coordinating other
aspects of cell physiology (5,6).
RAG1 protein is large, with 1040 amino acid residues
in the mouse (Figure 1).
Deletion analysis indicated that a sizable segment, resi-
dues 1–383 at the N-terminus, could be removed, along
with a shorter segment at the C-terminus, to yield a core
region that is active in V(D)J recombination in vitro and
in cells (7–9). Despite being recognized for years, the
function of the N-terminal region remains mysterious.
Its existence is conserved through the evolution of
RAG1, yet it clearly is not needed for the central enzy-
matic role as a recombinase. Sequence alignments show
that this region exhibits a greater divergence through evo-
lution than the enzymatic core (6). Notable in such align-
ments is the absolute conservation of a cluster of cystine
and histidine residues recognized as a special zinc-binding
motif termed a ‘RING ﬁnger’. RING structures have
been found in enzymes (E3 ligases) that help modify
other proteins through the covalent addition of small
modiﬁer proteins (10). In biochemical assays, the RAG1
N-terminus can act as an E3 ubiquitin ligase (11,12).
There is also phylogenetic evidence that the N-terminal
domain of RAG1 may have a separate origin, independent
of the nuclease-bearing core region (13).
These considerations suggest that RAG1, and
speciﬁcally the N-terminal domain, may act through
protein–protein interactions in ways that may modulate
or complement the nuclease activity of the core region
(14–16).
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To date, only the single protein Karyopherin a2 (also
known as KPNA2/RCH1/SRP1a/IPOA1/QIP2) has
been reported (17–19).
Here we explore the binding of the RAG1 N-terminal
domain with other proteins using the yeast two-hybrid
assay (20). We describe binding to two additional proteins
and ﬁnd that a critical interaction maps to a distinct pep-
tide motif in the RAG1 NTD.
MATERIALS AND METHODS
A yeast two-hybrid assay was conducted using
Matchmaker Two-Hybrid System 3 (Clontech,
Mountain View, CA), following the manufacturer’s
instructions. A Mouse T-cell lymphoma cDNA library
(Clontech ML4001AE) was obtained, comprised of 3 mil-
lion independent clones of 1.7kb average size, cloned
in the XhoI site of the pACT vector. The vector provides
a fusion to the GAL4-AD and selectable markers
[GAL4(768–881) AD, LEU2, Amp
r]. The library was ampli-
ﬁed once in Escherichia coli DH5a.
The RAG1 NTD was ampliﬁed by PCR from existing
mouse RAG1 templates using primers Forward-1aa
and Reverse-383aa (below), and cloned in pGBKT7
[GAL4(1–147) DNA-BD, TRP1, Kan
r] using the introduced
NcoI and XhoI sites. (NcoI and SalI in vector).
Simultaneous transformation of the RAG1 construct
and the library was performed into Saccharomyces
cerevisiae AH109 cells using the lithium acetate (0.1M
LiAc pH 7.5/40% polyethylene glycol/TE) method. Nine
million yeast transformants (representing a 3-fold over-
sampling) were screened on 500 plates of 15-cm diameter
at an average of 20000 transformants per plate. Cotrans-
formants were selected on minimal SD agar under permis-
sive ‘double drop out’ (DDO: -LEU/-TRP) conditions
or restrictive ‘triple drop out’ (TDO: -LEU/-TRP/-HIS)
conditions requiring two-hybrid interaction, as well as
TDO containing 2.5mM, 5mM and 7.5mM 3-AT
(3-amino1,2,4 triazole) (Sigma, St. Louis, MO, USA).
DNA was isolated from positive clones, sequenced using
a primer within the vector and recloned in pGADT7
[GAL4(768–881) AD, LEU2, Amp
r] for conﬁrmation.
Mammalian two-hybrid assay
Selected interacting proteins were tested for interaction
with RAG1 peptides in mammalian cells using the mam-
malian two-hybrid assay (Clontech Matchmaker). RAG1
peptides were recloned into the pM vector (Clontech
#K16021-1). Restriction sites in this vector were chosen
to preserve the reading frame from pGBKT7. Proteins
derived from the yeast screen were cloned in pVP16
(Clontech #K16021-1) with restriction sites in the same
reading frame as in the pGADT7 vector. The protein–
protein interaction was measured as Luciferase activity
utilizing plasmid pFR-LUC essentially as described (21).
Mammalian one-hybrid assay
The interaction of GMEB1 to RAG proteins at the 12RSS
was examined using the assay of Diﬁlippantonio et al.
(22). Reporter substrates were constructed by deleting
the Gal UAS from plasmid pFR-Luc, and inserting
12RSS sequences. The eight copies of 12RSS were
obtained from the original plasmid pMJD112 (6).
Details will be shared upon request. Plasmid GMEB1-
VP16 was a gift of Stoney Simons (NIH, Bethesda MD,
USA). Full-length RAG1-VP16 was derived from the core
RAG1-VP16 plasmid pCJM199 (6) by substitution.
RAG2 was expressed from the full-length T7 tagged plas-
mid used previously (23).
Luciferase assay
Luciferase activity was measured using the Dual-
Luciferase Reporter Assay System (Promega, Madison,
WI, USA) as per the manufacturer’s protocol. COS7
cells, grown to 70% conﬂuence on 6-cm culture plates,
were transfected (Fugene, Roche, Indianapolis, IN,
USA) using 3ml reagent per microgram DNA. Typically,
up to 6mg DNA was used per dish and extracted 48–72h
post-transfection in 400ml passive lysis buﬀer (30min on
ice). The supernatant measuring 100ml (following two
freeze–thaw cycles and centrifugation at 10000r.p.m. for
5min) was assayed in 96-well format using a LUMIstar
Galaxy luminometer and lumistar galaxy software (BMG
LABTECH, Durham, NC, USA).
Primers used for construction of RAG1 plasmids expressing segments of the N-terminal domain are listed
below. Included restriction sites are underlined
PCR Primer SEQUENCE
Forward-1aa 50 AAGCAACCATGGCTGCCTCCTTGCCGTCTACCCTG 30
Forward-104aa 50 CACCCCGGATCCGCCATGGCCAGGCTTAGACAC 30
Forward-139aa 50 CACCCCGGATCCGCCATGGCGCTTTTCCGAAAGAAG 30
Forward-173aa 50 CACCCCACTGAATTCTGCCAT 30
Forward-208aa 50 CAAAAAAGGATCCACACACCGTCCTGTGACATC 30
Reverse-224aa 50 CACCAAGTCGACTTATCAACTCTTCCTCTTGAGTCCCCG 30
Reverse-250aa 50 CACCAAGTCGACTTATCAAGTTCTCTTGCGACG 30
Reverse-383aa 50 AAGCCCCTCGAGTCATTACAAAGTCTCTTTAGATTCTTTGTG 30
Forward-250aa 50 AAAGTTCCATGGCAACTCAGGCTAGGGTCAGCAGCAAG 30
Reverse-350aa 50 AAAGGGCTCGAGTCACTAAGAATTCAAGATGTTCAGAAAGGACTTCAC 30
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digestion of existing constructs without PCR ampliﬁcation
using the natural EcoRI site at residue 173.
Alignments
Over 1000 RAG1 sequences were collected using the
NCBI PSI-Blast service (24) after ﬁve iterations seeded
with the coelacanth peptide spanning the WWL domain.
These sequences were then reformatted by ﬁltering based
on the taxonomic ID. The raw data sets are presented in
supplemental material. Selected sequences were aligned
using the CLC Sequence Viewer software (CLC Bio
USA, Cambridge, MA, USA) as implemented for the
Macintosh platform.
RESULTS
The N-terminal domain (NTD) of RAG1 comprises more
than one-third of the protein (Figure 1, top). Known
features within the NTD are the RING motif (residues
285–328) and clusters of basic residues. The core region
contains the acidic residues essential for the nuclease
activity (25,26) and known DNA-binding behavior. In
an eﬀort to explore whether the NTD alone was capable
of interacting with other proteins, we performed a yeast
two-hybrid screen (20). The RAG1 NTD was fused to the
yeast GAL4 DNA-binding domain (DNA-BD) (Figure 1,
bottom) and assayed for interaction with a library of
proteins each fused to the GAL4 transcriptional activation
domain (AD). We screened a library derived from a
mouse T-cell lymphoma, at a level (>9 million transfected
cells) calculated to exceed the representation of proteins
by several fold. The combination of plasmids and yeast
strains employed allowed screening and selection based on
several criteria. Selection for the presence of the DNA-BD
plasmid and an AD-expressing plasmid was provided
by two separate nutritional markers (leucine and tryp-
tophan). The interaction of the proteins activated a
third nutritional selection, for histidine through the
GAL1 UAS. The stringency of the histidine selection
was modulated by the level of an additional agent,
3-AT, (3-Amino-1,2,4-triazole), which is a competitive
inhibitor of the His3 protein. The concentration of this
inhibitor determines a minimal level of His3 expression
needed for survival. In addition, two-hybrid interaction
also activates three other reporters; ADE2, driven by
the GAL2 UAS promoter, b-galactosidase and MEL1
driven by the MEL1 promoter, the activity of which can
be used to conﬁrm the protein–protein interaction (data
not shown).
Eight isolates emerged from the screen, representing
three target proteins. Characterization of the initial
plasmids is portrayed (in part) in Figure 2A. Each of the
candidate target proteins is coexpressed with the empty
DNA-BD vector (sectors labeled 177) or with the
RAG1-NTD fusion (sectors labeled 179). All grow, as
expected, on the control double-drop out plates lacking
leucine and tryptophan (panel A, plate 4) but only candi-
dates that are capable of interaction with the NTD survive
on plates additionally lacking histidine, in the presence of
7.5mM 3-AT (panel A, plates 1–3). One selected target is
the protein Karyopherin a2 (also known as KPNA2/
RCH1/SRP1a/IPOA1/QIP2), previously recognized by
others using two-hybrid selection with full-length RAG1
as bait (17–19). This interaction served as a control in the
analysis that follows. The remaining two target proteins
have not been reported. These are splicing factor 3A2
Primers used for QuickChange (Strategene, La Jolla, CA, USA) mutagenesis of speciﬁc residues within the
WWL motif of RAG1
Name Sequence
W179A forward 50 TTCTGCCATGACTGTGCGAGCATCATGCACAGA 30
W179A reverse 50 TCTGTGCATGATGCTCGCACAGTCATGGCAGAA 30
VYF193AAA forward 50 AGTTCCCACAGTCAGGCCGCCGCCCCAAGGAAAGTGACC 30
VYF193AAA reverse 50 GGTCACTTTCCTTGGGGCGGCGGCCTGACTGTGGGAACT 30
W203A forward 50 AAAGTGACCGTGGAGGCGCACCCCCACACACCG 30
W203A reverse 50 CGGTGTGTGGGGGTGCGCCTCCACGGTCACTTT 30
WHP203AHA forward 50 AAAGTGACCGTGGAGGCGCACGCCCACACACACCGTCCTGT 30
WHP203AHA reverse 50 ACAGGACGGTGTGTGGGCGTGCGCCTCCACGGTCACTTT 30
Figure 1. (Top) Linear representation of the mouse RAG1 protein. The
central core region (384–1008) is marked in gray, with essential acidic
residues. The N-terminal region (residues 1–383) includes a previously
identiﬁed RING motif, several clusters of basic residues, and (in this
report) the WW-like domain. (Bottom) Representation of the two-
hybrid assay. The GAL4 DNA-binding domain (GAL4 DNA-BD) is
fused to the RAG1N-terminal domain (NTD) or smaller peptides. A
library of target proteins is obtained with each member fused to the
GAL4 activation domain (GAL4 AD). In yeast, the GAL4 DNA-BD
binds to the UAS element on a reporter construct. A protein–protein
interaction between a target protein and the RAG1 NTD protein posi-
tions the GAL4 AD to activate transcription of the His3 marker gene.
Nucleic Acids Research, 2009,Vol.37, No. 10 3303(SF3A2) and glucocorticoid modulatory element binding
protein 1 (GMEB1). The selected plasmids represented
(almost) the full-length GMEB1 protein. In contrast, the
several independent isolates of SF3A2 each were com-
posed of the identical C-terminal 145 residues of that
protein (Figure 2C). It is possible that this particular
clone was over-represented in the library. We note that
the residues selected are extraordinarily proline rich,
being composed largely of imperfect repeats of the
heptad PPAPGVH. The full SF3A2 protein is 475
amino acids long, of which the C-terminal 269 is 43%
proline and is largely composed of this same proline-rich
repeat (see supplement 1 in Supplementary Data).
Potential physiologic relevance of these interactions will
be discussed later.
We employed variations of the same two-hybrid assay
to help map the interactions shown above to smaller
regions of RAG1. Shorter peptides, designed to capture
or exclude known features in the RAG1-NTD, were
cloned in the same DNA-binding domain vector as used
above for the full NTD. Each of these constructs was
tested in the yeast two-hybrid assay with the three binding
partners. The results are presented in Figure 3. The basic
regions are labeled using the nomenclature of McMahan
et al. (16) as follows: BI 141-146, BIIa 218-224, BIIb
233-236, BIII 243-254. Dividing the NTD in half yielded
no growth with any target protein when tested with resi-
dues 1–173, and gave growth with all targets using the
segment 173–350. We note that the GMEB1 interaction
appears to be weaker in the assay of this last construct as
cell growth was observed only when the 3-AT concentra-
tion was reduced to 5mM. Similar growth, marked W in
the ﬁgure, was observed for GMEB1 with other constructs
as well. It is worth remembering, however, that the qual-
itative measure of growth employed here does not trans-
late reliably into a quantitative measure of protein
interaction. Other factors, such as the relative protein sta-
bility of the various constructs, or structural eﬀects that
diﬀer between constructs, also contribute to the behavior
of the system.
The RING motif was not required for the interaction
with these targets. Truncating the NTD at residue 250
(middle of BIII) was compatible with interaction with
all three targets, and the small fragment from 173 to 250
was positive in each case. Further deletion of the basic
residues between 224 and 250 (BIIb and BIII) interfered
with binding (construct containing RAG1 139–224), but
this could be restored by providing the basic region BI
(construct 104–224).
In yeast, the peptide 209–250 was suﬃcient to interact
with KPNA2 and GMEB1 but not with SF3A2 and sug-
gests that, for SF3A2at least, a structural contribution is
provided by the RAG1 peptide within residues 173–209.
We will return to this observation following further con-
ﬁrmation of the binding behavior of these target proteins
using other assays.
Translating the two-hybrid assay from yeast into mam-
malian cells seemed an important step in conﬁrming the
central observations. Two additional advantages are the
more physiologic environment for RAG1 function and
better quantitation of activity aﬀorded by the luciferase-
based assay. We employed a system that is conceptually
similar to that used above, but uses the herpes viral VP16
transactivation domain rather than the GAL4-AD.
Figure 2. (A) Yeast two-hybrid assay. Positive interaction between the
RAG1N-terminal domain and any member of the library of fusion
proteins allows growth under histidine-restrictive conditions (plates
1–3). In contrast, all cells grow on control double drop-out plates
(plate 4). (B) Three proteins were isolated, including the previously
known Karyopherin a2. (C) The isolated fragment of SF3A2 is
shown. It is composed largely of imperfect repeats of a proline-rich
heptad PPAPGVH.
Figure 3. Mapping interactions within the NTD by yeast two-hybrid.
Segments of RAG1 (solid lines) fused to GAL4 DNA-BD were tested
with the three binding targets. Ka=KPNA2, GM=GMEB1,
SF=SF3A2. (+) represents growth on histidine drop-out plates in
the presence of 7.5mM 3-AT. Weak growth (W) represents growth
with 5mM 3-AT. (–) represents no growth. ND is not determined.
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GAL4 DNA-BD, and the target proteins fused to VP16,
were cotransfected into COS7 cells, along with the
pFRLuc reporter. Extracts of these cells were assayed
for luciferase activity and the results tabulated in
Figure 4. For all three proteins, full-length RAG1 and
the NTD gave parallel positive evidence of interaction,
while the core region of RAG1 exhibited background
levels of activity. The constructs further truncated within
the NTD were largely consistent with the equivalent
assays performed in yeast. Most important, the short seg-
ment of RAG1 173–250 was again positive while trun-
cation into that segment from either side had striking
consequences. Removal of the basic region BIIb and
BIII (plasmid 173–224) prevented interaction with all
three target proteins. Truncation from the other direction,
(plasmid 209–250) still bound KPNA2 but lost interaction
with GMEB1 and SF3A2. We note that the behavior of
GMEB1 in this context diﬀers from the parallel experi-
ment in yeast in Figure 3. While we cannot fully account
for the diﬀerence, we feel the mammalian two-hybrid
result better reﬂects RAG1 behavior in its appropriate
context. These data therefore also indicate that the
region between 173 and 209 contains sequence that is
essential for the protein binding assayed here.
The luciferase assay was also used in a second context to
measure GMEB1 interaction with the RAG protein com-
plex. We adapted the one-hybrid assay (22) that had been
previously used to detect RAG1 and RAG2 binding to the
RSS. The authors of the original study used VP16 trans-
activator fusions to RAG1 and RAG2 to address the
occupancy of the RAG protein complex on DNA. Here
we extend that assay to demonstrate that GMEB1 fused
to VP16 can be recruited to the RSS through interaction
with the RAG1-NTD. Figure 5A shows the original
scheme. Three reporter plasmids encode luciferase driven
by a minimal promoter region and diﬀer by the number of
12RSS elements in the intervening spacer (zero, three or
eight RSS repeats). The previous study (22) showed that
binding of RAG proteins to the RSS depended on both
RAG1 and RAG2 coexpression. Panel 5B presents a
variation on this assay, where only GMEB1 carries the
VP16 transactivator. GMEB1 binding to RAG1 localized
to the RSS activates transcription of the luciferase
reporter. The results are tabulated in Figure 5C. We see,
using full-length or core RAG1-VP16, that the RAG
complex binds to the reporter plasmids, with luciferase
activity increasing with the number of RSS copies (lines
1 and 2). GMEB1-VP16, in the absence of the RAG pro-
tein complex, does not transactivate the luciferase (line 3).
GMEB-VP16 strongly transactivates the reporter when
full-length RAG1 protein (absent VP-16), coupled with
RAG2, binds the RSS elements (line 4). In contrast, core
RAG1 plus RAG2 do not recruit GMEB1-VP16 (line 5).
These data extend the results of the mammalian two-
hybrid by showing that GMEB1 is capable of binding to
RAG1 in the context of the RAG1/RAG2 complex situ-
ated on an RSS. One is struck by the magnitude by which
the GMEB-VP16 fusion drives transcription compared
to the relatively weak signal elicited by RAG1-VP16.
Alternatives include the possibility that the RAG1-VP16
fusion is intrinsically a poor transcriptional activator for
structural reasons, while the GMEB1-VP16 bound to
RAG1 is better able to activate the promoter. It is also
possible that the complex including GMEB1 binds DNA
better than the RAG complex alone. These questions are
under further study.
We return now to the observation (Figures 2 and 3),
that deletion of the RAG1 peptide residues 173–209 ren-
dered it unable to bind the SF3A2 fragment in yeast cells,
and both GMEB1 and the SF3A2 fragment in mammalian
cells. We had not chosen the endpoints for that deletion
arbitrarily. Owing to the striking proline-rich character of
the SF3A2 fragment, we examined the sequence of the
RAG1-NTD for motifs that would correspond to known
proline-binding domains. Such a correspondence can be
found with the domain called WW, for its two conserved
tryptophans (W).
Figure 5. One-hybrid assay adapted to show GMEB binding to RAG
proteins at the RSS. (A) The original one-hybrid assay (ref. 22). The
RAG protein complex, fused to VP16, activates luciferase when bound
to the 12RSS. (B) Modiﬁed one-hybrid assay is portrayed in which
VP-16 is only present fused to GMEB1. Activation of luciferase
requires protein–protein interaction between GMEB1 and the RAG
complex on the 12RSS. (C) Luciferase activity (machine units) obtained
from the listed combinations of proteins transfected into COS7 cells.
Figure 4. Mammalian two-hybrid results. The table presents luciferase
units (in thousands). DNA-BD RAG1 fusions interact with the target
proteins (as VP16 fusions) to activate a luciferase gene. Nomenclature
as in Figure 3.
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NTD and one well-studied WW domain, the fourth
WW domain in the mouse protein Itch (Genebank
NM_008395). The larger type emphasizes the important
conserved features. These include the two tryptophan resi-
dues (W) as well as an internal hydrophobic cluster often
containing a tyrosine (Y) and commonly, a proline two
residues C-terminal to the second tryptophan. The spacing
of the aligned residues within the RAG1 sequence does
not correspond precisely to the current deﬁnition so we
suggest calling the motif in RAG1 WW-like or WWL for
now. This sequence is highly conserved across all mam-
malian RAG1 sequences, as summarized in Figure 6B
(an alignment to 343 mammalian sequences is provided
in supplement 2 of the Supplementary Data). The consen-
sus is set at 90% stringency and shows complete conser-
vation of the deﬁning elements (although the tyrosine
residue is replaced by cystine in the dog). The conservation
is less absolute across the full vertebrate phylogeny.
Figure 6C shows representatives of the major vertebrate
radiations. Additional alignments are also presented in
Supplementary Data.
All mammals, amphibians, reptiles, turtles and crocodi-
lians preserve perfectly the two tryptophans and the
VYF hydrophobic core. The proline (mouse 206, boxed
in Figure 6B) is universally conserved among mammals
and crocodilians, but in reptiles, amphibians and turtles,
is often replaced by a serine.
Lizards show somewhat less conservation. Among
lizards, the blast alignment provided hits for 366 organ-
isms, of which 14% replaced the ﬁrst tryptophan with
arginine. One organism replaced the second tryptophan.
The hydrophobic core was frequently mutated with con-
servative replacements, and three organisms failed to con-
serve the proline (mouse 206).
Similarly with birds, we ﬁnd high conservation of
all residues, with speciﬁc replacement of the ﬁrst
tryptophan by arginine in 2% (15/741), replacement of
the VYF with VCF in 4% (33/741) of the species (as
was seen with the dog among mammals) and with six
other changes in this cluster. The second tryptophan is
perfectly conserved, and the proline (mouse 206) largely
conserved, with roughly 4% (28/741) arginines and two
cysteines substituting.
Figure 6. Alignments over the WW-L motif. (A) The mouse RAG1 WWL is aligned to Itch, an E3 ligase (genebank NM_008395, fourth WW
domain). Residues that contribute to the deﬁnition of the WW domain are highlighted in larger type. (B) Alignment of a wide selection of
representative mammals over the WWL region. (C) Alignment of selected RAG1 sequences from all vertebrates. Boxed residues in (B) and (C)
correspond to the deﬁning features in (A). Positions with a consensus that exceeds 90% are listed. Dots represent identities to the ﬁrst sequence;
dashes represent gaps. Genebank accession numbers for each sequence are listed on the right.
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boney ﬁsh, most importantly owing to the deletion of
residues between the ﬁrst tryptophan and the hydrophobic
core (VYF in mouse). While the ﬁnal phenylalanine (F)
is conserved, the tyrosine (Y) is lost, and it is not clear
whether this suﬃces for the hydrophobic core. The
remaining positions remain largely conserved. We have
no data addressing binding activity. It is possible that
function has been lost in these ﬁsh, although retained in
the Bull Shark.
Given the strong conservation, especially across mam-
mals, we chose to test whether mutation could conﬁrm a
functional role of these residues in binding interactions.
We prepared several mutated versions of the minimal
RAG1 construct used in Figure 4, spanning the region
173–250. We created single alanine substitutions at each
of the two tryptophan residues (W179A or W203A), the
double mutant containing W203A and P205A, and the
clustered replacement of three alanines for the three
hydrophobic residues (VYF193AAA). The constructs are
presented in Figure 7, along with the luciferase assays
reﬂecting the binding to each of the three interacting pro-
teins using the mammalian two-hybrid system. KPNA2
and GMEB1 each show only a modest reduction in bind-
ing ( 2-fold), which may be attributed to subtle eﬀects
on protein structure or stability within the RAG1 peptide.
In striking contrast, binding to the SF3A2 peptide shows
a 20-fold reduction in binding to each of the mutant
RAG1 proteins. These data are in complete accord with
the prediction that a WW-like domain is binding to a pro-
line-containing peptide. They suggest that the WW-like
domain plays a necessary role in stabilizing the interaction
with SF3A2 but is not as important for KPNA2 and
GMEB1. For these latter proteins, the interaction with
the basic region appears to be dominant.
DISCUSSION
The RAG proteins remain the only identiﬁed cell-speciﬁc
factors required for V(D)J recombination. Biochemical
studies indicate that the RAG proteins alone are suﬃcient
to recognize the RSS in vitro, and perform the initial DNA
cleavages. However, the recombination reaction requires
many additional steps, and the extent to which the RAG
proteins participate before and following cleavage remains
largely speculative. On natural chromatin, the initial bind-
ing is constrained by accessibility and there is evidence of
protein–protein interactions with nucleosomes (27–29).
We believe that additional protein–protein interactions
remain to be described. These are likely to shape the dis-
tribution of recombination events, the consequences of
recombination, and the state of the cell during the recom-
bination reaction. One avenue by which RAG1 could
mediate eﬀects beyond its role as a nuclease is through
an ubiquitin ligase activity mapped to the N-terminal
domain (11,12).
This report reveals additional protein–protein interac-
tions by means of a yeast two-hybrid screen using the
RAG1 N-terminal domain as one binding partner.
Previous yeast two-hybrid screens, by others, used the
entire RAG1 protein. Three groups reported interaction
with the protein Karyopherin a2, also called Srp1a and
Rch1 (17–19). In our hands, this protein binds only to the
NTD, but the core protein still localizes to the nucleus.
Our screen reiterated the binding to KPNA2, and revealed
binding to two others; a C-terminal segment of Splicing
Factor 3A subunit 2 (SF3A2, also known as SF3a66) and
the GMEB1 also called PIF p96 (30,31).
Only a brief description of the activities of these
proteins will be provided here, until we have more evi-
dence of function in V(D)J recombination. KPNA2 is
recognized as a nuclear transport protein. As a complex
with b-karyopherin, it has a second role as an activator of
the proteasome (32,33).
Although the interaction with an RNA splicing protein
seems far aﬁeld for RAG1, a previous report found that
RAG1, when overexpressed, localized to the nucleolus
(19). This was interpreted as reﬂecting a direct RNA-
binding behavior, but it may actually reﬂect binding
to this RNA-processing protein. Two other binding inter-
actions with SF3A2 appear to be independent of a role
in splicing. One group ﬁnds this protein tethers to the
microtubules in the nucleus (34). A second ﬁnds that a
developmental transcription factor (nuclear FGF-2)
binds this factor in neurons (35).
GMEB1 is a transcription factor initially described
as a cofactor of genes controlled by the glucocorticoid
receptor. Subsequently, it has been found to contribute
to the regulation of many genes (36), and bind the
CREB-binding protein CBP (30). GMEB1 binding is
regulated by DNA methylation. GMEB1 is already
known to bind a RING-containing ubiquitin E3 ligase
and play a regulatory role in muscle (37). GMEB1 also
interacts with the SUMO pathway. One important func-
tion seems to be recruiting Ubc9, the SUMO-speciﬁc E2
enzyme, to transcription complexes (38). The GMEB1
heterodimer with GMEB2 is associated with a DNA nick-
ing activity. It is a host factor, which binds and activates
a mouse parvovirus viral DNA nickase during viral repli-
cation (31). GMEB1 also blocks pro-apoptosis signals
induced by a variety of stresses (39).
Figure 7. The eﬀect of site speciﬁc mutations within the WWL motif
using the mammalian two-hybrid assay. (Top) Mouse RAG1 from
173-206, spanning the WWL motif. Residues in larger font are
variously mutated. (Bottom) Mammalian two-hybrid assay revealing
interaction between the RAG1 peptide and the three other proteins.
Data are raw luciferase units. The interaction with SF3A2 is very sen-
sitive to all mutations.
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proteins onto RAG1 and deﬁned small peptides that were
able to mediate this interaction using the two-hybrid
assay. Two diﬀerent transactivation domains were used
between the yeast and mammalian assays. The segment
of RAG1 including residues 173–250 was suﬃcient to
recapitulate the interactions with all three targets analyzed
here (Figures 3 and 4). The luciferase assay yielded
roughly 50% of the activity using this short peptide, com-
pared to the full NTD, indicating that we have isolated a
major component to this interaction. Better quantitation
of the binding will require in vitro analysis, not subject
to confounding eﬀects of diﬀering protein expression or
stability, or structural constraints contributed by the
fusion partners.
The segment 173–250 contains clusters of basic residues
previously designated as the BIIa, BIIb, and (most of)
BIII. It also contains the motif we are designating WWL
(for WW-like). The basic clusters, by themselves, appear
suﬃcient for interaction with KPNA2 (Figures 3 and 4;
RAG1 209–250). In the mammalian two-hybrid assay, the
other two proteins appear to require both an interaction
within the WWL motif and a basic region. Truncation
from the C-terminal side to residue 224, removing the
BIIb and BIII clusters, eliminated binding to all three
interacting proteins in both yeast and mammalian assays
(RAG1 139–224 in Figure 3, and RAG1 173–224 in
Figure 4). Curiously, adding additional sequence to the
N-terminal side restored binding to all three proteins, as
seen in Figure 3 RAG1 104–224. Two explanations are
consistent with these data. Either the segment from 104
to 139 provides an alternate binding motif, or the change
in spacing allows the basic region BI to function better as
a substitute than when it was positioned at the junction
with the GAL4-BD fusion partner. In summary, a small
cluster of basic residues alone appears to be suﬃcient
for interaction with KPNA2. In contrast, the proteins
GMEB1 and SF3A2 bound best to constructs that pro-
vided the WWL motif accompanied by a basic cluster,
which could be located on either side.
The motif we consider WW-like shares several proper-
ties with canonical WW domains. As described by the
Conserved Domain Database (40) http://www.ncbi.nlm.
nih.gov/Structure/cdd/cddsrv.cgi?uid=119576 the ‘two
conserved tryptophans’ (WW) domain is composed of
around 40 residues and functions as an interaction
module in a diverse set of signaling proteins. It binds spe-
ciﬁc proline-rich sequences at low aﬃnities. We note that
several ubiquitin ligases bind their substrates through the
action or one or several associated WW domains. To date,
these are all HECT type E3 ligases and include the Smurf
proteins, the NEDD4 family, Itch and Suppressor of
Deltex.
Canonical WW domains share a protein structure in
which the ﬁrst tryptophan contributes to the folding of
the domain, while the internal hydrophobic core (fre-
quently a tyrosine) and the second tryptophan form
hydrophobic stacks with a proline of the binding ligand
(41). None of these positions needs to be absolutely con-
served but the spacing between these features does not
match the spacing observed in RAG1. Speciﬁcally, the
canonical motif [calculated from the 100 most diverse
members of the conserved domain database for motif
cd00201, (40)] is spaced W (X9–11)Y( X 9–14) W XX P.
The RAG1 (mammalian alignment in Figure 6B) sequence
is W (X14)Y( X 8) W X P. Our mutational data using the
mammalian two-hybrid assay (Figure 7) support our pro-
posal of a structure that mimics the canonical WW
domain. Mutation of the deﬁning features of the WW
motif, single-point mutations of the tryptophans, or of
the hydrophobic cluster including the tyrosine, reduced
binding activity to the SP3A2 proline-rich ligand by over
20-fold as determined by the mammalian two-hybrid
assay.
Also noteworthy are the two potential metal-binding
motifs CxxC that bracket the WWL (conserved in
Figure 6B and C). Were these to cooperatively bind
a metal ion, they would structurally constrain and
approximate the ends of the WWL motif. We have not
yet examined their function in isolation.
Examination of the phylogenetic alignment (Figure 6
and Supplementary Data) reinforces the signiﬁcance of
the WWL motif. The relatively infrequent mutations at
the signature residues are highly constrained in identity.
We conclude by noting that, although we detected new
binding interactions with the RAG1 NTD, we did not
detect interaction with the RING motif. Such an interac-
tion is expected between proteins behaving as an ubiquitin
E3 and their necessary partners, the E2 proteins. It is
the case, however, that two-hybrid assays have not been
successful in detecting other such E3–E2 interactions.
This may reﬂect the weak signal that is likely to be gener-
ated by a relatively transient interaction. The two-hybrid
approach is most sensitive to stable binding. The new
interacting partners we did detect reveal a previously
uncharacterized motif within RAG1 that seems to
behave similarly to the WW family. We suspect that pro-
tein–protein interactions with RAG1 could inﬂuence
DNA binding and signaling as the recombination reaction
progresses.
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